Filter Results
:
(115)
Show Results For
-
All HBS Web
(115)
- News (42)
- Research (57)
- Multimedia (1)
- Faculty Publications (37)
Show Results For
-
All HBS Web
(115)
- News (42)
- Research (57)
- Multimedia (1)
- Faculty Publications (37)
- 01 Jun 2012
- News
In Brief
global strategy, a new position. More Social Enterprise Start-Ups Recognized for Bold Ideas Diabetes is one of the leading causes of death and disability in the developing world, affecting nearly 250 million people. Yet most can't afford...
View Details
- 05 Jan 2010
- First Look
First Look: January 5
there be strategic returns down the line? Purchase this case: http://cb.hbsp.harvard.edu/cb/product/710016-PDF-ENG The Joslin Diabetes Center Michael E. Porter, Elizabeth Olmsted Teisberg, and Scott WallaceHarvard Business School Case...
View Details
Keywords:
Martha Lagace
- 01 Sep 2004
- News
A Market-Based Prescription
and nephrologist. In a focused factory, all these resources are integrated. These diabetic specialists jointly develop treatment protocols and pricing. Together, they offer a full range of services customized for this disease. Research...
View Details
- 05 Jan 2011
- Op-Ed
Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress
get money. If they can't get money, they lay off people and cancel projects. Now imagine you are a postdoc in a lab and are working on a project to use human embryonic stem cells to cure diabetes by creating new beta cells in the...
View Details
- 20 Jan 2015
- News
Patient Medical Records, Pocket-sized
doctors and hospitals.” “No provider has all of your records,” says Bushkin, adding that a study published in the Journal of Patient Safety found that 440,000 Americans die annually as the result of medical errors. “Someone who is a View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that different situations will require different business...
View Details
- 14 May 2014
- News
(Re)moving the Needle
2009), the company's cofounder and CEO. The device, which is powered by an electric motor, is highly customizable across a variety of medical, animal, agricultural, and cosmetic applications. One major market, says Anquetil, is diabetes...
View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
Genomic Research. Even the impetus for common diseases such as diabetes and hypertension continues to elude scientists, he said. Eric S. Lander But that will change. The major achievement that underlies biology and medicine today is that...
View Details
- 06 Apr 2023
- Blog Post
Circularity in Denmark
publicly-held companies. Novo Nordisk Foundation, owner of Novo Nordisk (the world’s leader in diabetes and obesity care), has a net worth of approximately 94 billion euros and awarded 1.2 billion euros in grants in 2021, putting it in...
View Details
- 30 Jun 2017
- News
Rebuilding the Girl Scouts Brand
Juvenile Diabetes Research Foundation, had a brand problem: the disease it addressed was no longer known as juvenile diabetes, as children and adults were being diagnosed in equal numbers. Pitter-Armand was charged with repositioning the...
View Details
Keywords:
April White
- 27 Jul 2017
- News
Seeing a Way Forward
due to the condition. In addition, 3 percent of Mexicans suffer from glaucoma and 7 percent of diabetics in Mexico are needlessly blind. According to salauno, only 30 percent of the Mexicans who need corrective vision procedures or...
View Details
Keywords:
Jennifer Myers
- 24 Jan 2005
- Research & Ideas
Entrepreneurial Hospital Pioneers New Model
her own physician. Reflecting on his background, Shetty wrote on his Web site that he became a doctor because of the recurrent illnesses of his parents. As a child he lived in fear that he would lose his mother; his father, a diabetic, suffered several View Details
- 23 Sep 2019
- Blog Post
Distressed Employees? Try Resilience Training
times more likely to experience work-related problems than employees with chronic physical illnesses like diabetes or heart disease. So why do many companies fail to help their workers battle mental health disorders? “There’s a silence...
View Details
Keywords:
All Industries
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow treatment regimens for chronic...
View Details
Keywords:
by Regina E. Herzlinger
- 01 Dec 2010
- News
Chaotic Funding Derails Research
diabetes by creating new beta cells in the pancreas. This is difficult work that is high risk but high reward. You have come to grips with the many ethical considerations in working with stem cells derived from embryos that were created...
View Details
- 01 Sep 2008
- News
Mara Aspinall
pharmaceutical companies focused their R&D on treatments for common illnesses — such as diabetes and high cholesterol — an approach that resulted in the development of blockbuster drugs. We now recognize that diseases are far more complex...
View Details
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
then could be tested experimentally. Studying doctors and patients The research team devised two experiments, one involving primary care doctors, the other, patients. In the first experiment, the researchers asked physicians to evaluate hypothetical View Details
- 09 Oct 2018
- First Look
New Research and Ideas, October 9, 2018
provide focused, comprehensive care for two high-volume and expensive medical conditions: type-1 diabetes and morbid obesity. Purchase this case:https://hbsp.harvard.edu/product/718471-PDF-ENG Harvard Business School 417-023 Kurt Summers:...
View Details
Keywords:
Dina Gerdeman
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
drug, Afrezza. MannKind would thus be the only company with an inhalable insulin on the market. As an alternative to injectable rapid-acting (or mealtime) insulin, Afrezza boasted a potential market of at least 4 million diabetic...
View Details
Keywords:
Sean Silverthorne
- 13 Dec 2022
- News
The First Five Years: Christine Keung and Reggie Smith
Christine Keung (at podium) and Reginald Smith (both MBA 2020) present recommendations for economic development to the West Virginia State Senate in May 2022. How did you meet? Reggie Smith: "We first met before classes started RC year at a big social event in...
View Details